Rare diseases: positive results of a phase 3 study for the treatment of idiopathic hypersomnia
Idiopathic hypersomnia: results of the international phase 3 clinical trial, sponsored by Jazz Pharmaceuticals and published in Lancet Neurology, showed a clinically positive improvement in the overall severity of idiopathic hypersomnia…